CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 156 filers reported holding CLOVIS ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $21,438,000 | -73.6% | 612,500 | -30.6% | 2.44% | -66.5% |
| Q3 2015 | $81,190,000 | +11.7% | 882,891 | +6.8% | 7.26% | +37.2% |
| Q2 2015 | $72,670,000 | +18.4% | 826,919 | 0.0% | 5.29% | +41.7% |
| Q1 2015 | $61,383,000 | +38.7% | 826,919 | +4.6% | 3.74% | +42.3% |
| Q4 2014 | $44,271,000 | +23.5% | 790,555 | 0.0% | 2.63% | +2.3% |
| Q3 2014 | $35,860,000 | +9.5% | 790,555 | 0.0% | 2.57% | +22.5% |
| Q2 2014 | $32,737,000 | -40.2% | 790,555 | 0.0% | 2.10% | -38.1% |
| Q1 2014 | $54,761,000 | +14.9% | 790,555 | 0.0% | 3.39% | +23.2% |
| Q4 2013 | $47,646,000 | -0.9% | 790,555 | 0.0% | 2.75% | -3.6% |
| Q3 2013 | $48,066,000 | -22.4% | 790,555 | -14.5% | 2.85% | -22.4% |
| Q2 2013 | $61,957,000 | – | 925,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |